Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
US-11116721-B2 · Sep 14, 2021 · US
Bruce Mark holds 1 patent in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 1 |
| Recent patents | 0 |
| First publication | Sep 14, 2021 |
| Latest publication | Sep 14, 2021 |
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2021 | 1 |
| Year | Patents |
|---|---|
| 2021 | 1 |
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K45/06 | 1 |
| A61P11/00 | 1 |
| A61K31/58 | 1 |
| A61P11/06 | 1 |
| A61K31/138 | 1 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1 |